243 related articles for article (PubMed ID: 35792986)
1. Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer.
Suelmann BBM; Rademaker A; van Dooijeweert C; van der Wall E; van Diest PJ; Moelans CB
Cell Oncol (Dordr); 2022 Aug; 45(4):591-600. PubMed ID: 35792986
[TBL] [Abstract][Full Text] [Related]
2. Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database.
Bae SY; Kim SJ; Lee J; Lee ES; Kim EK; Park HY; Suh YJ; Kim HK; You JY; Jung SP
Breast Cancer Res Treat; 2018 Nov; 172(1):113-121. PubMed ID: 30088177
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
Bae SY; Jung SP; Jung ES; Park SM; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ
Oncology; 2018; 95(3):163-169. PubMed ID: 29913459
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile.
Suelmann BBM; van Dooijeweert C; van der Wall E; Linn S; van Diest PJ
Breast Cancer Res Treat; 2021 Apr; 186(3):699-704. PubMed ID: 33635448
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.
Loo LW; Wang Y; Flynn EM; Lund MJ; Bowles EJ; Buist DS; Liff JM; Flagg EW; Coates RJ; Eley JW; Hsu L; Porter PL
Breast Cancer Res Treat; 2011 May; 127(1):297-308. PubMed ID: 21264507
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.
Madaras L; Kovács KA; Szász AM; Kenessey I; Tőkés AM; Székely B; Baranyák Z; Kiss O; Dank M; Kulka J
Pathol Oncol Res; 2014 Jul; 20(3):581-90. PubMed ID: 24357159
[TBL] [Abstract][Full Text] [Related]
8. QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation.
Bhattarai S; Sugita BM; Bortoletto SM; Fonseca AS; Cavalli LR; Aneja R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768979
[TBL] [Abstract][Full Text] [Related]
9. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
[TBL] [Abstract][Full Text] [Related]
10. Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi M; Ling Y; Toshikawa C; Hayashida T; Kitagawa Y; Futamura M; Kuwayama T; Nakamura S; Yamauchi H; Yamauchi T; Kaneko K; Kanbayashi C; Sato N; Tsuchida J; Moro K; Nakajima M; Shimada Y; Ichikawa H; Lyle S; Miyoshi Y; Takabe K; Okuda S; Wakai T
Breast Cancer; 2023 Jul; 30(4):584-595. PubMed ID: 36930419
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network.
Puchar A; Despierres M; Boudy AS; Selleret L; Gligorov J; Richard S; Zilberman S; Ferrier C; Dabi Y; Varlas V; Thomassin-Naggara I; Bendifallah S; Touboul C; Darai E
Breast; 2022 Feb; 61():168-174. PubMed ID: 35042133
[TBL] [Abstract][Full Text] [Related]
12. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
[TBL] [Abstract][Full Text] [Related]
13. Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
Matar R; Crown A; Sevilimedu V; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2022 Mar; 29(3):1695-1702. PubMed ID: 34709494
[TBL] [Abstract][Full Text] [Related]
14. Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.
Kikuchi-Koike R; Nagasaka K; Tsuda H; Ishii Y; Sakamoto M; Kikuchi Y; Fukui S; Miyagawa Y; Hiraike H; Kobayashi T; Kinoshita T; Kanai Y; Shibata T; Imoto I; Inazawa J; Matsubara O; Ayabe T
BMC Cancer; 2019 May; 19(1):521. PubMed ID: 31146704
[TBL] [Abstract][Full Text] [Related]
15. Survival of women with pregnancy-associated breast cancer according to clinical characteristics: A propensity score matching study.
Gwak H; Woo SS; Lee ES; Park MH; Lee S; Youn HJ; Park S; Suh IS; Kim SH
Medicine (Baltimore); 2022 Oct; 101(40):e30831. PubMed ID: 36221366
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China.
Han BY; Li XG; Zhao HY; Hu X; Ling H
BMC Cancer; 2020 Mar; 20(1):244. PubMed ID: 32293328
[TBL] [Abstract][Full Text] [Related]
17. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
Elife; 2020 Jan; 9():. PubMed ID: 31939734
[TBL] [Abstract][Full Text] [Related]
18. Behavior and Outcomes of Pregnancy Associated Breast Cancer.
Suleman K; Osmani AH; Al Hashem H; Al Twegieri T; Ajarim D; Jastaniyah N; Al Khayal W; Al Malik O; Al Sayed A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):135-138. PubMed ID: 30678424
[TBL] [Abstract][Full Text] [Related]
19. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
[TBL] [Abstract][Full Text] [Related]
20. Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer.
Silvestri M; Dugo M; Vismara M; De Cecco L; Lanzoni D; Vingiani A; Folli S; De Santis MC; de Braud F; Pruneri G; Di Cosimo S; Cappelletti V
Sci Rep; 2022 Jan; 12(1):1470. PubMed ID: 35087134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
